Cynthia J. Aki

Person

Livingston, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,964,646
- Issue date Jun 21, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,947,720
- Issue date May 24, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiadiazoles as CXC- and CC- chemokine receptor ligands
- Patent number 7,786,149
- Issue date Aug 31, 2010
- Schering Corp.
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...
- Patent number 7,691,856
- Issue date Apr 6, 2010
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
- Patent number 7,338,968
- Issue date Mar 4, 2008
- Schering Corporation
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CXCR1 and CXCR2 chemokine antagonists
- Patent number 7,326,729
- Issue date Feb 5, 2008
- Schering Corporation
- Jianhua Chao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,132,445
- Issue date Nov 7, 2006
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesyl protein transferase inhibitors
- Patent number 6,740,661
- Issue date May 25, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesyl protein transferase inhibitors
- Patent number 6,372,747
- Issue date Apr 16, 2002
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...
- Publication number 20110213029
- Publication date Sep 1, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...
- Publication number 20090306079
- Publication date Dec 10, 2009
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS
- Publication number 20080090823
- Publication date Apr 17, 2008
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...
- Publication number 20070264230
- Publication date Nov 15, 2007
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS
- Publication number 20070248594
- Publication date Oct 25, 2007
- Schering Corporation
- Jianhua Chao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20070021494
- Publication date Jan 25, 2007
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
- Publication number 20060223864
- Publication date Oct 5, 2006
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CXCR1 and CXCR2 chemokine antagonists
- Publication number 20060014794
- Publication date Jan 19, 2006
- Schering Corporation
- Jianhua Chao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040235908
- Publication date Nov 25, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine...
- Publication number 20040186142
- Publication date Sep 23, 2004
- Schering Corporation Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040147559
- Publication date Jul 29, 2004
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040106794
- Publication date Jun 3, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040097547
- Publication date May 20, 2004
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine recepto...
- Publication number 20030204085
- Publication date Oct 30, 2003
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor...
- Publication number 20030097004
- Publication date May 22, 2003
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Farnesyl protein transferase inhibitors
- Publication number 20020103207
- Publication date Aug 1, 2002
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Cynthia J. Aki

Person

Patents Grantslast 30 patents

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Thiadiazoles as CXC- and CC- chemokine receptor ligands

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...

Thiadiazoles AS CXC- and CC- chemokine receptor ligands

CXCR1 and CXCR2 chemokine antagonists

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Farnesyl protein transferase inhibitors

Farnesyl protein transferase inhibitors

Patents Applicationslast 30 patents

3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...

THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...

CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Thiadiazoles AS CXC- and CC- chemokine receptor ligands

CXCR1 and CXCR2 chemokine antagonists

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine recepto...

3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor...

Farnesyl protein transferase inhibitors